Cargando…

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study

BACKGROUND: In October 2012, the Chinese government established maximum retail prices for specific products, including 30 antineoplastic medications. Three years later, in June 2015, the government abolished price regulation for most medications, including all antineoplastic medications. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Xiaodong, Wushouer, Haishaerjiang, Yang, Mingchun, Han, Sheng, Shi, Luwen, Ross-Degnan, Dennis, Wagner, Anita Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924745/ https://www.ncbi.nlm.nih.gov/pubmed/31784440 http://dx.doi.org/10.1136/bmjopen-2019-031658

Ejemplares similares

Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
por: Zhang, Yichen, et al.
Publicado: (2021)

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
por: Guan, Xiaodong, et al.
Publicado: (2018)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
por: Huang, Cong, et al.
Publicado: (2021)

Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China
por: Fu, Mengyuan, et al.
Publicado: (2021)

Impact of China’s healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study
por: Zhu, Dawei, et al.
Publicado: (2019)

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis
por: Sruamsiri, Rosarin, et al.
Publicado: (2016)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
por: Huang, Tao, et al.
Publicado: (2022)

Drug pricing and reimbursement decision making systems in Mongolia
por: Dorj, Gereltuya, et al.
Publicado: (2017)

Price Trends of Core and Non-core Foods in Thailand: An Analysis of Consumer Price Index
por: Ngoc, Hung Nguyen, et al.
Publicado: (2022)

Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015
por: Zhou, Yue, et al.
Publicado: (2020)

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
por: Bai, Lin, et al.
Publicado: (2020)

Sugar Price Supports and Taxation: A Public Health Policy Paradox
por: Dilk, Abby, et al.
Publicado: (2017)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

The influence of Medicare Part D on the list pricing of brand drugs
por: Ippolito, Benedic N., et al.
Publicado: (2023)

The Effects of Prices on Alcohol Use and its Consequences
por: Xu, Xin, et al.
Publicado: (2011)

Estimation of Value-Based Price for 48 High-Technology Medical Devices
por: Hyeraci, Giulia, et al.
Publicado: (2023)

Changes in Alcohol Availability, Price and Alcohol-related Problems and the Collectivity of Drinking Cultures: What Happened in Southern and Northern Sweden?(†)
por: Gustafsson, Nina-Katri
Publicado: (2010)

Impact of minimum unit pricing on alcohol-related hospital outcomes: systematic review
por: Maharaj, Tobias, et al.
Publicado: (2023)

Secular trend analysis of antibiotic utilisation in China’s hospitals 2011–2018, a retrospective analysis of procurement data
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Outpatient Antibiotic Prescribing Patterns and Appropriateness for Children in Primary Healthcare Settings in Beijing City, China, 2017–2019
por: Wushouer, Haishaerjiang, et al.
Publicado: (2021)

The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China
por: Hu, Lin, et al.
Publicado: (2022)

Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study
por: Garabedian, Laura Faden, et al.
Publicado: (2012)

Asset pricing implications of good governance
por: Lehnert, Thorsten
Publicado: (2019)

Effects of drug price reduction and prescribing restrictions on expenditures and utilisation of antihypertensive drugs in Korea
por: Yoo, Ki-Bong, et al.
Publicado: (2015)

What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences
por: Chapman, Stephen R, et al.
Publicado: (2017)

Implementation of medicines pricing policies in sub-Saharan Africa: protocol for a systematic review
por: Mirzoev, Tolib, et al.
Publicado: (2021)

Impact of the Low-Price Medicine Policy on Medicine Supply in China: An Interrupted Time-Series Analysis
por: Zhao, Mingyue, et al.
Publicado: (2021)

Deregulation and pricing of medical services: a policy experiment based in China
por: Zang, Wenbin, et al.
Publicado: (2021)

A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals
por: Guan, Xiaodong, et al.
Publicado: (2018)

The impact of physicians’ knowledge on outpatient antibiotic use: Evidence from China's county hospitals
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Protocol of a tailored educational intervention for general practitioners on potentially inappropriate medications among older patients at community healthcare institutions in Beijing, China: a cluster-randomised controlled trial
por: Fu, Mengyuan, et al.
Publicado: (2021)

Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?
por: Srivastava, Divya, et al.
Publicado: (2014)

Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China
por: Sun, Xiaoluan, et al.
Publicado: (2018)

Perspectives on econometric modelling to inform policy: a UK qualitative case study of minimum unit pricing of alcohol
por: Katikireddi, Srinivasa V., et al.
Publicado: (2014)

Trends in the costs of drugs launched in the UK between 1981 and 2015: an analysis of the launch price of drugs in five disease areas
por: Ward, Derek J, et al.
Publicado: (2019)

Does price regulation affect atorvastatin sales in India? An impact assessment through interrupted time series analysis
por: Selvaraj, Sakthivel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l93cqkn35g45vkv22htm081mar